We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
+12.43%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$414M
AUM Growth
+$26.7M
(+6.9%)
Cap. Flow
-$16.2M
Cap. Flow
% of AUM
-3.92%
Top 10 Holdings %
Top 10 Hldgs %
45.26%
Holding
68
New
4
Increased
5
Reduced
48
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$3.8M |
| 2 |
Ulta Beauty
ULTA
|
+$2.62M |
| 3 |
Valvoline
VVV
|
+$2.46M |
| 4 |
RELX
RELX
|
+$2.1M |
| 5 |
MRSH
Marsh
MRSH
|
+$1.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.35M |
| 2 |
Check Point Software Technologies
CHKP
|
+$2.23M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.17M |
| 4 |
SAP
SAP
|
+$2.13M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.3% |
| 2 | Technology | 20.94% |
| 3 | Industrials | 17.6% |
| 4 | Consumer Staples | 13.89% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Unilever
UL
$137B
| $1.9M | 0.46% |
28,037
-3,660
| -12% | -$248K |
|
|
NVO
52
Novo Nordisk
NVO
$208B
| $1.59M | 0.38% |
45,644
-52
| -0.1% | -$1.8K |
|
53
Coca-Cola Femsa
KOF
$22.7B
| $1.44M | 0.35% |
31,158
-3,686
| -11% | -$160K |
|
54
Abbott
ABT
$183B
| $1.4M | 0.34% |
12,800
| – | – |
|
55
Compañía de Cervecerías Unidas
CCU
$2.12B
| $1.34M | 0.32% |
91,195
-17,657
| -16% | -$240K |
|
56
AbbVie
ABBV
$443B
| $1.31M | 0.32% |
12,200
| – | – |
|
57
Diageo
DEO
$49B
| $1.16M | 0.28% |
7,316
-979
| -12% | -$146K |
|
58
IDEX
IEX
$17B
| $1.16M | 0.28% |
5,833
-84
| -1% | -$16K |
|
59
KT
KT
$8.62B
| $1.06M | 0.26% |
96,161
-17,926
| -16% | -$189K |
|
60
Kraft Heinz
KHC
$30.7B
| $638K | 0.15% |
18,418
| – | – |
|
61
Procter & Gamble
PG
$336B
| $547K | 0.13% |
3,932
| – | – |
|
62
Yum China
YUMC
$16.5B
| $501K | 0.12% |
8,773
-1,331
| -13% | -$74.7K |
|
63
Vanguard S&P 500 ETF
VOO
$993B
| $428K | 0.1% |
1,244
| – | – |
|
64
Viatris
VTRS
$20.4B
| $352K | 0.09% |
+18,798
| New | +$307K |
|
65
Vanguard ESG US Stock ETF
ESGV
$13.3B
| $298K | 0.07% |
4,243
-110
| -3% | -$7.26K |
|
|
66
Check Point Software Technologies
CHKP
$13B
| – | – |
-18,552
| Closed | -$2.23M |
|
|
67
SAP
SAP
$212B
| – | – |
-13,694
| Closed | -$2.13M |
|
|
WBA
68
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-49,155
| Closed | -$1.77M |
|
Similar funds
HCM
GS
IA
PAMS
SSWG
JWM
GDS
GPP
Foyston, Gordon, & Payne's Q4 2020 Portfolio in Review
As of Q4 2020, Foyston, Gordon, & Payne held 68 positions worth $414M, up 6.9% from $388M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $16.2M in Q4 2020, closing 3 positions and reducing 48 holdings. Its most notable exit was Check Point Software Technologies, an estimated $2.23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
Against the trend, Foyston, Gordon, & Payne opened a new position in Equifax worth $4.36M.
- Foyston, Gordon, & Payne's largest Q4 2020 buy was Equifax: 22,604 shares worth $4.36M.
- Foyston, Gordon, & Payne added most to Ulta Beauty in Q4 2020, an estimated $2.62M increase.
- Foyston, Gordon, & Payne's biggest Q4 2020 reduction was Microsoft, cutting an estimated $2.35M.
- Foyston, Gordon, & Payne fully exited Check Point Software Technologies in Q4 2020, selling an estimated $2.23M.
- Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $414M portfolio in Q4 2020.
- Foyston, Gordon, & Payne opened 4 new positions and closed 3 in Q4 2020.
- Foyston, Gordon, & Payne's portfolio value rose 6.9% quarter-over-quarter to $414M.
Based on Foyston, Gordon, & Payne's 13F filing for Q4 2020, filed 12 Feb 2021.